Blockade of CB1 activation attenuates obesity by affecting multiple areas including leptin signaling, white adipose tissue browning, gut microbiota interactions, and reducing inflammation (5, 6, 8, 9, 18, 36). This evidence concerns the gene CNR1 and Obesity.